Chacón-Quirós M. Breast tissue preservation: a paradigm shift in aesthetic breast surgery. Clin Plast Surg. 2026;53:255-265. doi: 10.1016/j.cps.2025.11.015
Disclosure
Dr. Epstein is a paid investigator in the Motiva U.S. FDA clinical trial and is compensated by Establishment Labs to train surgeons on the Preservé breast augmentation technique. He discloses this relationship in all public communications involving Motiva or Preservé. Dr. Epstein owns stock in Establishment Labs.
What This Study Found
This is a review article, not a patient study, that lays out the guiding principles behind breast tissue preservation as a surgical philosophy: keeping the breast's natural cellular, structural, and functional integrity intact, using minimally invasive tools, and specifically avoiding electrocautery and the thermal injury that comes with it.
Key Findings
- Defines breast tissue preservation (BTP) as prioritizing native anatomy over a "reshape and enlarge" approach
- Built on minimally invasive instrumentation, 3D pre-operative planning, and preservation of natural tissue planes
- Specifically calls out avoiding electrocautery-related thermal injury as a core design principle
- Summarizes existing clinical evidence pointing to reduced complications, faster recovery, and high patient satisfaction
Why This Matters for Preservé Patients
This is the best single "big picture" explainer for why the technique exists at all, good as an introductory or philosophy-focused page rather than a data-heavy one.
